it is not a dosing recommendation
Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides
Middle Phase (Days 7-21) Pain reduction and visible healing progress typically become noticeable within the 5-10 day range
Different administration routes solve different problems
Without enough, you might feel tired, weak, and have nerve problems
If, if you're battling dementia or Alzheimer's, you know, that's another huge one